Global cfDNA Testing Market Growth (Status and Outlook) 2026-2032
The global cfDNA Testing market size is predicted to grow from US$ 9892 million in 2025 to US$ 19588 million in 2032; it is expected to grow at a CAGR of 10.5% from 2026 to 2032.
cfDNA testing is a precision medicine service that involves collecting human bodily fluid samples (such as blood or urine) to extract extracellular DNA fragments. By employing molecular detection technologies—including next-generation sequencing (NGS), droplet digital PCR (ddPCR), standard PCR, and methylation analysis—these fragments are analyzed for gene mutations, chromosomal abnormalities, methylation patterns, and genomic information to facilitate disease screening, diagnosis, treatment monitoring, and prognostic assessment. cfDNA originates primarily from DNA released during normal cell apoptosis and from DNA shed by specialized tissues such as tumor cells and placental cells; tumor-derived cfDNA (ctDNA) is utilized for cancer liquid biopsies, while non-invasive prenatal testing (NIPT) screens for chromosomal abnormalities using fetal-derived cfDNA found in maternal blood. Compared to traditional tissue biopsies, cfDNA testing offers advantages such as being minimally invasive, allowing for repeated sampling, and providing a real-time reflection of disease status, making it a key technological direction in liquid biopsy and precision medicine.
Driven by the rapid advancement of global precision medicine, liquid biopsy, and genetic testing technologies, the cfDNA testing market holds significant growth potential. In oncology, the rising demand for early cancer screening, monitoring of minimal residual disease (MRD), and companion diagnostics for targeted therapies has established ctDNA testing as a vital tool for precision diagnosis and treatment. In the field of obstetrics and gynecology, NIPT has emerged as one of the most commercially mature applications of cfDNA testing. Furthermore, new applications—such as organ transplant monitoring, genetic disease screening, and infectious disease detection—are continuously expanding. Looking ahead, as sequencing costs decrease, AI-assisted analysis capabilities improve, and testing standards are refined, cfDNA testing will evolve from single-disease detection toward multi-cancer early screening, dynamic health monitoring, and personalized treatment. The global cfDNA testing market is projected to maintain a compound annual growth rate (CAGR) of over 10%, positioning it as a rapidly growing segment within the molecular diagnostics industry.
Report Scope
LPI (LP Information)' newest research report, the “cfDNA Testing Industry Forecast” looks at past sales and reviews total world cfDNA Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected cfDNA Testing sales for 2026 through 2032. With cfDNA Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world cfDNA Testing industry.
This Insight Report provides a comprehensive analysis of the global cfDNA Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on cfDNA Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global cfDNA Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for cfDNA Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global cfDNA Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of cfDNA Testing market by product type, application, key players and key regions and countries.
cfDNA testing is a precision medicine service that involves collecting human bodily fluid samples (such as blood or urine) to extract extracellular DNA fragments. By employing molecular detection technologies—including next-generation sequencing (NGS), droplet digital PCR (ddPCR), standard PCR, and methylation analysis—these fragments are analyzed for gene mutations, chromosomal abnormalities, methylation patterns, and genomic information to facilitate disease screening, diagnosis, treatment monitoring, and prognostic assessment. cfDNA originates primarily from DNA released during normal cell apoptosis and from DNA shed by specialized tissues such as tumor cells and placental cells; tumor-derived cfDNA (ctDNA) is utilized for cancer liquid biopsies, while non-invasive prenatal testing (NIPT) screens for chromosomal abnormalities using fetal-derived cfDNA found in maternal blood. Compared to traditional tissue biopsies, cfDNA testing offers advantages such as being minimally invasive, allowing for repeated sampling, and providing a real-time reflection of disease status, making it a key technological direction in liquid biopsy and precision medicine.
Driven by the rapid advancement of global precision medicine, liquid biopsy, and genetic testing technologies, the cfDNA testing market holds significant growth potential. In oncology, the rising demand for early cancer screening, monitoring of minimal residual disease (MRD), and companion diagnostics for targeted therapies has established ctDNA testing as a vital tool for precision diagnosis and treatment. In the field of obstetrics and gynecology, NIPT has emerged as one of the most commercially mature applications of cfDNA testing. Furthermore, new applications—such as organ transplant monitoring, genetic disease screening, and infectious disease detection—are continuously expanding. Looking ahead, as sequencing costs decrease, AI-assisted analysis capabilities improve, and testing standards are refined, cfDNA testing will evolve from single-disease detection toward multi-cancer early screening, dynamic health monitoring, and personalized treatment. The global cfDNA testing market is projected to maintain a compound annual growth rate (CAGR) of over 10%, positioning it as a rapidly growing segment within the molecular diagnostics industry.
Report Scope
LPI (LP Information)' newest research report, the “cfDNA Testing Industry Forecast” looks at past sales and reviews total world cfDNA Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected cfDNA Testing sales for 2026 through 2032. With cfDNA Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world cfDNA Testing industry.
This Insight Report provides a comprehensive analysis of the global cfDNA Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on cfDNA Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global cfDNA Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for cfDNA Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global cfDNA Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of cfDNA Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Targeted Sequencing
- Whole Genome Sequencing
Segmentation by Test Type:
- Services
- Reagent Kits
- Others
- LDT (Laboratory-Driven Treatment) Services for Healthcare Institutions
- DTC (Direct-to-Consumer) Services for Consumers
Segmentation by Application:
- Prenatal Testing
- Oncology
- Organ Transplant Monitoring
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- NIPT by LifeCodexx
- Genodive Pharma
- Riken Genesis
- GC Genome
- EDGC
- Natera
- CareDx
- BillionToOne, Inc.
- ARUP Laboratories
- Guardant Health
- GRAIL
- Foundation Medicine
- MedGenome
- Lucence
- BGI Genomics
- Berry Genomics
- Burning Rock
- ACT Genomics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global cfDNA Testing Market Size (2021-2032)
2.1.2 cfDNA Testing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for cfDNA Testing by Country/Region (2021, 2025 & 2032)
2.2 cfDNA Testing Segment by Type
2.2.1 Targeted Sequencing
2.2.2 Whole Genome Sequencing
2.2.3 cfDNA Testing Market Size by Type
2.2.3.1 cfDNA Testing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global cfDNA Testing Market Size Market Share by Type (2021-2026)
2.3 cfDNA Testing Segment by Test Type
2.3.1 Services
2.3.2 Reagent Kits
2.3.3 Others
2.3.4 cfDNA Testing Market Size by Test Type
2.3.4.1 cfDNA Testing Market Size CAGR by Test Type (2021 VS 2025 VS 2032)
2.3.4.2 Global cfDNA Testing Market Size Market Share by Test Type (2021-2026)
2.4 cfDNA Testing Segment Target Audiences
2.4.1 LDT (Laboratory-Driven Treatment) Services for Healthcare Institutions
2.4.2 DTC (Direct-to-Consumer) Services for Consumers
2.4.3 cfDNA Testing Market Size Target Audiences
2.4.3.1 cfDNA Testing Market Size CAGR Target Audiences (2021 VS 2025 VS 2032)
2.4.3.2 Global cfDNA Testing Market Size Market Share Target Audiences (2021-2026)
2.5 cfDNA Testing Segment by Application
2.5.1 Prenatal Testing
2.5.2 Oncology
2.5.3 Organ Transplant Monitoring
2.5.4 Others
2.5.5 cfDNA Testing Market Size by Application
2.5.5.1 cfDNA Testing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global cfDNA Testing Market Size Market Share by Application (2021-2026)
3 CFDNA TESTING MARKET SIZE BY PLAYER
3.1 cfDNA Testing Market Size Market Share by Player
3.1.1 Global cfDNA Testing Revenue by Player (2021-2026)
3.1.2 Global cfDNA Testing Revenue Market Share by Player (2021-2026)
3.2 Global cfDNA Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CFDNA TESTING BY REGION
4.1 cfDNA Testing Market Size by Region (2021-2026)
4.2 Global cfDNA Testing Annual Revenue by Country/Region (2021-2026)
4.3 Americas cfDNA Testing Market Size Growth (2021-2026)
4.4 APAC cfDNA Testing Market Size Growth (2021-2026)
4.5 Europe cfDNA Testing Market Size Growth (2021-2026)
4.6 Middle East & Africa cfDNA Testing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas cfDNA Testing Market Size by Country (2021-2026)
5.2 Americas cfDNA Testing Market Size by Type (2021-2026)
5.3 Americas cfDNA Testing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC cfDNA Testing Market Size by Region (2021-2026)
6.2 APAC cfDNA Testing Market Size by Type (2021-2026)
6.3 APAC cfDNA Testing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe cfDNA Testing Market Size by Country (2021-2026)
7.2 Europe cfDNA Testing Market Size by Type (2021-2026)
7.3 Europe cfDNA Testing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa cfDNA Testing by Region (2021-2026)
8.2 Middle East & Africa cfDNA Testing Market Size by Type (2021-2026)
8.3 Middle East & Africa cfDNA Testing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CFDNA TESTING MARKET FORECAST
10.1 Global cfDNA Testing Forecast by Region (2027-2032)
10.1.1 Global cfDNA Testing Forecast by Region (2027-2032)
10.1.2 Americas cfDNA Testing Forecast
10.1.3 APAC cfDNA Testing Forecast
10.1.4 Europe cfDNA Testing Forecast
10.1.5 Middle East & Africa cfDNA Testing Forecast
10.2 Americas cfDNA Testing Forecast by Country (2027-2032)
10.2.1 United States Market cfDNA Testing Forecast
10.2.2 Canada Market cfDNA Testing Forecast
10.2.3 Mexico Market cfDNA Testing Forecast
10.2.4 Brazil Market cfDNA Testing Forecast
10.3 APAC cfDNA Testing Forecast by Region (2027-2032)
10.3.1 China cfDNA Testing Market Forecast
10.3.2 Japan Market cfDNA Testing Forecast
10.3.3 Korea Market cfDNA Testing Forecast
10.3.4 Southeast Asia Market cfDNA Testing Forecast
10.3.5 India Market cfDNA Testing Forecast
10.3.6 Australia Market cfDNA Testing Forecast
10.4 Europe cfDNA Testing Forecast by Country (2027-2032)
10.4.1 Germany Market cfDNA Testing Forecast
10.4.2 France Market cfDNA Testing Forecast
10.4.3 UK Market cfDNA Testing Forecast
10.4.4 Italy Market cfDNA Testing Forecast
10.4.5 Russia Market cfDNA Testing Forecast
10.5 Middle East & Africa cfDNA Testing Forecast by Region (2027-2032)
10.5.1 Egypt Market cfDNA Testing Forecast
10.5.2 South Africa Market cfDNA Testing Forecast
10.5.3 Israel Market cfDNA Testing Forecast
10.5.4 Turkey Market cfDNA Testing Forecast
10.6 Global cfDNA Testing Forecast by Type (2027-2032)
10.7 Global cfDNA Testing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market cfDNA Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 NIPT by LifeCodexx
11.1.1 NIPT by LifeCodexx Company Information
11.1.2 NIPT by LifeCodexx cfDNA Testing Product Offered
11.1.3 NIPT by LifeCodexx cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 NIPT by LifeCodexx Main Business Overview
11.1.5 NIPT by LifeCodexx Latest Developments
11.2 Genodive Pharma
11.2.1 Genodive Pharma Company Information
11.2.2 Genodive Pharma cfDNA Testing Product Offered
11.2.3 Genodive Pharma cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Genodive Pharma Main Business Overview
11.2.5 Genodive Pharma Latest Developments
11.3 Riken Genesis
11.3.1 Riken Genesis Company Information
11.3.2 Riken Genesis cfDNA Testing Product Offered
11.3.3 Riken Genesis cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Riken Genesis Main Business Overview
11.3.5 Riken Genesis Latest Developments
11.4 GC Genome
11.4.1 GC Genome Company Information
11.4.2 GC Genome cfDNA Testing Product Offered
11.4.3 GC Genome cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 GC Genome Main Business Overview
11.4.5 GC Genome Latest Developments
11.5 EDGC
11.5.1 EDGC Company Information
11.5.2 EDGC cfDNA Testing Product Offered
11.5.3 EDGC cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 EDGC Main Business Overview
11.5.5 EDGC Latest Developments
11.6 Natera
11.6.1 Natera Company Information
11.6.2 Natera cfDNA Testing Product Offered
11.6.3 Natera cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Natera Main Business Overview
11.6.5 Natera Latest Developments
11.7 CareDx
11.7.1 CareDx Company Information
11.7.2 CareDx cfDNA Testing Product Offered
11.7.3 CareDx cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 CareDx Main Business Overview
11.7.5 CareDx Latest Developments
11.8 BillionToOne, Inc.
11.8.1 BillionToOne, Inc. Company Information
11.8.2 BillionToOne, Inc. cfDNA Testing Product Offered
11.8.3 BillionToOne, Inc. cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 BillionToOne, Inc. Main Business Overview
11.8.5 BillionToOne, Inc. Latest Developments
11.9 ARUP Laboratories
11.9.1 ARUP Laboratories Company Information
11.9.2 ARUP Laboratories cfDNA Testing Product Offered
11.9.3 ARUP Laboratories cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 ARUP Laboratories Main Business Overview
11.9.5 ARUP Laboratories Latest Developments
11.10 Guardant Health
11.10.1 Guardant Health Company Information
11.10.2 Guardant Health cfDNA Testing Product Offered
11.10.3 Guardant Health cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Guardant Health Main Business Overview
11.10.5 Guardant Health Latest Developments
11.11 GRAIL
11.11.1 GRAIL Company Information
11.11.2 GRAIL cfDNA Testing Product Offered
11.11.3 GRAIL cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 GRAIL Main Business Overview
11.11.5 GRAIL Latest Developments
11.12 Foundation Medicine
11.12.1 Foundation Medicine Company Information
11.12.2 Foundation Medicine cfDNA Testing Product Offered
11.12.3 Foundation Medicine cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Foundation Medicine Main Business Overview
11.12.5 Foundation Medicine Latest Developments
11.13 MedGenome
11.13.1 MedGenome Company Information
11.13.2 MedGenome cfDNA Testing Product Offered
11.13.3 MedGenome cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 MedGenome Main Business Overview
11.13.5 MedGenome Latest Developments
11.14 Lucence
11.14.1 Lucence Company Information
11.14.2 Lucence cfDNA Testing Product Offered
11.14.3 Lucence cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Lucence Main Business Overview
11.14.5 Lucence Latest Developments
11.15 BGI Genomics
11.15.1 BGI Genomics Company Information
11.15.2 BGI Genomics cfDNA Testing Product Offered
11.15.3 BGI Genomics cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 BGI Genomics Main Business Overview
11.15.5 BGI Genomics Latest Developments
11.16 Berry Genomics
11.16.1 Berry Genomics Company Information
11.16.2 Berry Genomics cfDNA Testing Product Offered
11.16.3 Berry Genomics cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Berry Genomics Main Business Overview
11.16.5 Berry Genomics Latest Developments
11.17 Burning Rock
11.17.1 Burning Rock Company Information
11.17.2 Burning Rock cfDNA Testing Product Offered
11.17.3 Burning Rock cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Burning Rock Main Business Overview
11.17.5 Burning Rock Latest Developments
11.18 ACT Genomics
11.18.1 ACT Genomics Company Information
11.18.2 ACT Genomics cfDNA Testing Product Offered
11.18.3 ACT Genomics cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 ACT Genomics Main Business Overview
11.18.5 ACT Genomics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global cfDNA Testing Market Size (2021-2032)
2.1.2 cfDNA Testing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for cfDNA Testing by Country/Region (2021, 2025 & 2032)
2.2 cfDNA Testing Segment by Type
2.2.1 Targeted Sequencing
2.2.2 Whole Genome Sequencing
2.2.3 cfDNA Testing Market Size by Type
2.2.3.1 cfDNA Testing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global cfDNA Testing Market Size Market Share by Type (2021-2026)
2.3 cfDNA Testing Segment by Test Type
2.3.1 Services
2.3.2 Reagent Kits
2.3.3 Others
2.3.4 cfDNA Testing Market Size by Test Type
2.3.4.1 cfDNA Testing Market Size CAGR by Test Type (2021 VS 2025 VS 2032)
2.3.4.2 Global cfDNA Testing Market Size Market Share by Test Type (2021-2026)
2.4 cfDNA Testing Segment Target Audiences
2.4.1 LDT (Laboratory-Driven Treatment) Services for Healthcare Institutions
2.4.2 DTC (Direct-to-Consumer) Services for Consumers
2.4.3 cfDNA Testing Market Size Target Audiences
2.4.3.1 cfDNA Testing Market Size CAGR Target Audiences (2021 VS 2025 VS 2032)
2.4.3.2 Global cfDNA Testing Market Size Market Share Target Audiences (2021-2026)
2.5 cfDNA Testing Segment by Application
2.5.1 Prenatal Testing
2.5.2 Oncology
2.5.3 Organ Transplant Monitoring
2.5.4 Others
2.5.5 cfDNA Testing Market Size by Application
2.5.5.1 cfDNA Testing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global cfDNA Testing Market Size Market Share by Application (2021-2026)
3 CFDNA TESTING MARKET SIZE BY PLAYER
3.1 cfDNA Testing Market Size Market Share by Player
3.1.1 Global cfDNA Testing Revenue by Player (2021-2026)
3.1.2 Global cfDNA Testing Revenue Market Share by Player (2021-2026)
3.2 Global cfDNA Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CFDNA TESTING BY REGION
4.1 cfDNA Testing Market Size by Region (2021-2026)
4.2 Global cfDNA Testing Annual Revenue by Country/Region (2021-2026)
4.3 Americas cfDNA Testing Market Size Growth (2021-2026)
4.4 APAC cfDNA Testing Market Size Growth (2021-2026)
4.5 Europe cfDNA Testing Market Size Growth (2021-2026)
4.6 Middle East & Africa cfDNA Testing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas cfDNA Testing Market Size by Country (2021-2026)
5.2 Americas cfDNA Testing Market Size by Type (2021-2026)
5.3 Americas cfDNA Testing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC cfDNA Testing Market Size by Region (2021-2026)
6.2 APAC cfDNA Testing Market Size by Type (2021-2026)
6.3 APAC cfDNA Testing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe cfDNA Testing Market Size by Country (2021-2026)
7.2 Europe cfDNA Testing Market Size by Type (2021-2026)
7.3 Europe cfDNA Testing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa cfDNA Testing by Region (2021-2026)
8.2 Middle East & Africa cfDNA Testing Market Size by Type (2021-2026)
8.3 Middle East & Africa cfDNA Testing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CFDNA TESTING MARKET FORECAST
10.1 Global cfDNA Testing Forecast by Region (2027-2032)
10.1.1 Global cfDNA Testing Forecast by Region (2027-2032)
10.1.2 Americas cfDNA Testing Forecast
10.1.3 APAC cfDNA Testing Forecast
10.1.4 Europe cfDNA Testing Forecast
10.1.5 Middle East & Africa cfDNA Testing Forecast
10.2 Americas cfDNA Testing Forecast by Country (2027-2032)
10.2.1 United States Market cfDNA Testing Forecast
10.2.2 Canada Market cfDNA Testing Forecast
10.2.3 Mexico Market cfDNA Testing Forecast
10.2.4 Brazil Market cfDNA Testing Forecast
10.3 APAC cfDNA Testing Forecast by Region (2027-2032)
10.3.1 China cfDNA Testing Market Forecast
10.3.2 Japan Market cfDNA Testing Forecast
10.3.3 Korea Market cfDNA Testing Forecast
10.3.4 Southeast Asia Market cfDNA Testing Forecast
10.3.5 India Market cfDNA Testing Forecast
10.3.6 Australia Market cfDNA Testing Forecast
10.4 Europe cfDNA Testing Forecast by Country (2027-2032)
10.4.1 Germany Market cfDNA Testing Forecast
10.4.2 France Market cfDNA Testing Forecast
10.4.3 UK Market cfDNA Testing Forecast
10.4.4 Italy Market cfDNA Testing Forecast
10.4.5 Russia Market cfDNA Testing Forecast
10.5 Middle East & Africa cfDNA Testing Forecast by Region (2027-2032)
10.5.1 Egypt Market cfDNA Testing Forecast
10.5.2 South Africa Market cfDNA Testing Forecast
10.5.3 Israel Market cfDNA Testing Forecast
10.5.4 Turkey Market cfDNA Testing Forecast
10.6 Global cfDNA Testing Forecast by Type (2027-2032)
10.7 Global cfDNA Testing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market cfDNA Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 NIPT by LifeCodexx
11.1.1 NIPT by LifeCodexx Company Information
11.1.2 NIPT by LifeCodexx cfDNA Testing Product Offered
11.1.3 NIPT by LifeCodexx cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 NIPT by LifeCodexx Main Business Overview
11.1.5 NIPT by LifeCodexx Latest Developments
11.2 Genodive Pharma
11.2.1 Genodive Pharma Company Information
11.2.2 Genodive Pharma cfDNA Testing Product Offered
11.2.3 Genodive Pharma cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Genodive Pharma Main Business Overview
11.2.5 Genodive Pharma Latest Developments
11.3 Riken Genesis
11.3.1 Riken Genesis Company Information
11.3.2 Riken Genesis cfDNA Testing Product Offered
11.3.3 Riken Genesis cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Riken Genesis Main Business Overview
11.3.5 Riken Genesis Latest Developments
11.4 GC Genome
11.4.1 GC Genome Company Information
11.4.2 GC Genome cfDNA Testing Product Offered
11.4.3 GC Genome cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 GC Genome Main Business Overview
11.4.5 GC Genome Latest Developments
11.5 EDGC
11.5.1 EDGC Company Information
11.5.2 EDGC cfDNA Testing Product Offered
11.5.3 EDGC cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 EDGC Main Business Overview
11.5.5 EDGC Latest Developments
11.6 Natera
11.6.1 Natera Company Information
11.6.2 Natera cfDNA Testing Product Offered
11.6.3 Natera cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Natera Main Business Overview
11.6.5 Natera Latest Developments
11.7 CareDx
11.7.1 CareDx Company Information
11.7.2 CareDx cfDNA Testing Product Offered
11.7.3 CareDx cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 CareDx Main Business Overview
11.7.5 CareDx Latest Developments
11.8 BillionToOne, Inc.
11.8.1 BillionToOne, Inc. Company Information
11.8.2 BillionToOne, Inc. cfDNA Testing Product Offered
11.8.3 BillionToOne, Inc. cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 BillionToOne, Inc. Main Business Overview
11.8.5 BillionToOne, Inc. Latest Developments
11.9 ARUP Laboratories
11.9.1 ARUP Laboratories Company Information
11.9.2 ARUP Laboratories cfDNA Testing Product Offered
11.9.3 ARUP Laboratories cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 ARUP Laboratories Main Business Overview
11.9.5 ARUP Laboratories Latest Developments
11.10 Guardant Health
11.10.1 Guardant Health Company Information
11.10.2 Guardant Health cfDNA Testing Product Offered
11.10.3 Guardant Health cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Guardant Health Main Business Overview
11.10.5 Guardant Health Latest Developments
11.11 GRAIL
11.11.1 GRAIL Company Information
11.11.2 GRAIL cfDNA Testing Product Offered
11.11.3 GRAIL cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 GRAIL Main Business Overview
11.11.5 GRAIL Latest Developments
11.12 Foundation Medicine
11.12.1 Foundation Medicine Company Information
11.12.2 Foundation Medicine cfDNA Testing Product Offered
11.12.3 Foundation Medicine cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Foundation Medicine Main Business Overview
11.12.5 Foundation Medicine Latest Developments
11.13 MedGenome
11.13.1 MedGenome Company Information
11.13.2 MedGenome cfDNA Testing Product Offered
11.13.3 MedGenome cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 MedGenome Main Business Overview
11.13.5 MedGenome Latest Developments
11.14 Lucence
11.14.1 Lucence Company Information
11.14.2 Lucence cfDNA Testing Product Offered
11.14.3 Lucence cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Lucence Main Business Overview
11.14.5 Lucence Latest Developments
11.15 BGI Genomics
11.15.1 BGI Genomics Company Information
11.15.2 BGI Genomics cfDNA Testing Product Offered
11.15.3 BGI Genomics cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 BGI Genomics Main Business Overview
11.15.5 BGI Genomics Latest Developments
11.16 Berry Genomics
11.16.1 Berry Genomics Company Information
11.16.2 Berry Genomics cfDNA Testing Product Offered
11.16.3 Berry Genomics cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Berry Genomics Main Business Overview
11.16.5 Berry Genomics Latest Developments
11.17 Burning Rock
11.17.1 Burning Rock Company Information
11.17.2 Burning Rock cfDNA Testing Product Offered
11.17.3 Burning Rock cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Burning Rock Main Business Overview
11.17.5 Burning Rock Latest Developments
11.18 ACT Genomics
11.18.1 ACT Genomics Company Information
11.18.2 ACT Genomics cfDNA Testing Product Offered
11.18.3 ACT Genomics cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 ACT Genomics Main Business Overview
11.18.5 ACT Genomics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. cfDNA Testing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. cfDNA Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Targeted Sequencing
Table 4. Major Players of Whole Genome Sequencing
Table 5. cfDNA Testing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global cfDNA Testing Market Size by Type (2021-2026) & ($ millions)
Table 7. Global cfDNA Testing Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Services
Table 9. Major Players of Reagent Kits
Table 10. Major Players of Others
Table 11. cfDNA Testing Market Size CAGR by Test Type (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global cfDNA Testing Market Size by Test Type (2021-2026) & ($ millions)
Table 13. Global cfDNA Testing Market Size Market Share by Test Type (2021-2026)
Table 14. Major Players of LDT (Laboratory-Driven Treatment) Services for Healthcare Institutions
Table 15. Major Players of DTC (Direct-to-Consumer) Services for Consumers
Table 16. cfDNA Testing Market Size CAGR Target Audiences (2021 VS 2025 VS 2032) & ($ millions)
Table 17. Global cfDNA Testing Market Size Target Audiences (2021-2026) & ($ millions)
Table 18. Global cfDNA Testing Market Size Market Share Target Audiences (2021-2026)
Table 19. cfDNA Testing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global cfDNA Testing Market Size by Application (2021-2026) & ($ millions)
Table 21. Global cfDNA Testing Market Size Market Share by Application (2021-2026)
Table 22. Global cfDNA Testing Revenue by Player (2021-2026) & ($ millions)
Table 23. Global cfDNA Testing Revenue Market Share by Player (2021-2026)
Table 24. cfDNA Testing Key Players Head office and Products Offered
Table 25. cfDNA Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global cfDNA Testing Market Size by Region (2021-2026) & ($ millions)
Table 29. Global cfDNA Testing Market Size Market Share by Region (2021-2026)
Table 30. Global cfDNA Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 31. Global cfDNA Testing Revenue Market Share by Country/Region (2021-2026)
Table 32. Americas cfDNA Testing Market Size by Country (2021-2026) & ($ millions)
Table 33. Americas cfDNA Testing Market Size Market Share by Country (2021-2026)
Table 34. Americas cfDNA Testing Market Size by Type (2021-2026) & ($ millions)
Table 35. Americas cfDNA Testing Market Size Market Share by Type (2021-2026)
Table 36. Americas cfDNA Testing Market Size by Application (2021-2026) & ($ millions)
Table 37. Americas cfDNA Testing Market Size Market Share by Application (2021-2026)
Table 38. APAC cfDNA Testing Market Size by Region (2021-2026) & ($ millions)
Table 39. APAC cfDNA Testing Market Size Market Share by Region (2021-2026)
Table 40. APAC cfDNA Testing Market Size by Type (2021-2026) & ($ millions)
Table 41. APAC cfDNA Testing Market Size by Application (2021-2026) & ($ millions)
Table 42. Europe cfDNA Testing Market Size by Country (2021-2026) & ($ millions)
Table 43. Europe cfDNA Testing Market Size Market Share by Country (2021-2026)
Table 44. Europe cfDNA Testing Market Size by Type (2021-2026) & ($ millions)
Table 45. Europe cfDNA Testing Market Size by Application (2021-2026) & ($ millions)
Table 46. Middle East & Africa cfDNA Testing Market Size by Region (2021-2026) & ($ millions)
Table 47. Middle East & Africa cfDNA Testing Market Size by Type (2021-2026) & ($ millions)
Table 48. Middle East & Africa cfDNA Testing Market Size by Application (2021-2026) & ($ millions)
Table 49. Key Market Drivers & Growth Opportunities of cfDNA Testing
Table 50. Key Market Challenges & Risks of cfDNA Testing
Table 51. Key Industry Trends of cfDNA Testing
Table 52. Global cfDNA Testing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 53. Global cfDNA Testing Market Size Market Share Forecast by Region (2027-2032)
Table 54. Global cfDNA Testing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 55. Global cfDNA Testing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 56. NIPT by LifeCodexx Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 57. NIPT by LifeCodexx cfDNA Testing Product Offered
Table 58. NIPT by LifeCodexx cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. NIPT by LifeCodexx Main Business
Table 60. NIPT by LifeCodexx Latest Developments
Table 61. Genodive Pharma Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 62. Genodive Pharma cfDNA Testing Product Offered
Table 63. Genodive Pharma cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Genodive Pharma Main Business
Table 65. Genodive Pharma Latest Developments
Table 66. Riken Genesis Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 67. Riken Genesis cfDNA Testing Product Offered
Table 68. Riken Genesis cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Riken Genesis Main Business
Table 70. Riken Genesis Latest Developments
Table 71. GC Genome Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 72. GC Genome cfDNA Testing Product Offered
Table 73. GC Genome cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. GC Genome Main Business
Table 75. GC Genome Latest Developments
Table 76. EDGC Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 77. EDGC cfDNA Testing Product Offered
Table 78. EDGC cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. EDGC Main Business
Table 80. EDGC Latest Developments
Table 81. Natera Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 82. Natera cfDNA Testing Product Offered
Table 83. Natera cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Natera Main Business
Table 85. Natera Latest Developments
Table 86. CareDx Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 87. CareDx cfDNA Testing Product Offered
Table 88. CareDx cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. CareDx Main Business
Table 90. CareDx Latest Developments
Table 91. BillionToOne, Inc. Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 92. BillionToOne, Inc. cfDNA Testing Product Offered
Table 93. BillionToOne, Inc. cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. BillionToOne, Inc. Main Business
Table 95. BillionToOne, Inc. Latest Developments
Table 96. ARUP Laboratories Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 97. ARUP Laboratories cfDNA Testing Product Offered
Table 98. ARUP Laboratories cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. ARUP Laboratories Main Business
Table 100. ARUP Laboratories Latest Developments
Table 101. Guardant Health Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 102. Guardant Health cfDNA Testing Product Offered
Table 103. Guardant Health cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Guardant Health Main Business
Table 105. Guardant Health Latest Developments
Table 106. GRAIL Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 107. GRAIL cfDNA Testing Product Offered
Table 108. GRAIL cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. GRAIL Main Business
Table 110. GRAIL Latest Developments
Table 111. Foundation Medicine Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 112. Foundation Medicine cfDNA Testing Product Offered
Table 113. Foundation Medicine cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Foundation Medicine Main Business
Table 115. Foundation Medicine Latest Developments
Table 116. MedGenome Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 117. MedGenome cfDNA Testing Product Offered
Table 118. MedGenome cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. MedGenome Main Business
Table 120. MedGenome Latest Developments
Table 121. Lucence Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 122. Lucence cfDNA Testing Product Offered
Table 123. Lucence cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Lucence Main Business
Table 125. Lucence Latest Developments
Table 126. BGI Genomics Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 127. BGI Genomics cfDNA Testing Product Offered
Table 128. BGI Genomics cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. BGI Genomics Main Business
Table 130. BGI Genomics Latest Developments
Table 131. Berry Genomics Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 132. Berry Genomics cfDNA Testing Product Offered
Table 133. Berry Genomics cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Berry Genomics Main Business
Table 135. Berry Genomics Latest Developments
Table 136. Burning Rock Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 137. Burning Rock cfDNA Testing Product Offered
Table 138. Burning Rock cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Burning Rock Main Business
Table 140. Burning Rock Latest Developments
Table 141. ACT Genomics Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 142. ACT Genomics cfDNA Testing Product Offered
Table 143. ACT Genomics cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. ACT Genomics Main Business
Table 145. ACT Genomics Latest Developments
Table 1. cfDNA Testing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. cfDNA Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Targeted Sequencing
Table 4. Major Players of Whole Genome Sequencing
Table 5. cfDNA Testing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global cfDNA Testing Market Size by Type (2021-2026) & ($ millions)
Table 7. Global cfDNA Testing Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Services
Table 9. Major Players of Reagent Kits
Table 10. Major Players of Others
Table 11. cfDNA Testing Market Size CAGR by Test Type (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global cfDNA Testing Market Size by Test Type (2021-2026) & ($ millions)
Table 13. Global cfDNA Testing Market Size Market Share by Test Type (2021-2026)
Table 14. Major Players of LDT (Laboratory-Driven Treatment) Services for Healthcare Institutions
Table 15. Major Players of DTC (Direct-to-Consumer) Services for Consumers
Table 16. cfDNA Testing Market Size CAGR Target Audiences (2021 VS 2025 VS 2032) & ($ millions)
Table 17. Global cfDNA Testing Market Size Target Audiences (2021-2026) & ($ millions)
Table 18. Global cfDNA Testing Market Size Market Share Target Audiences (2021-2026)
Table 19. cfDNA Testing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global cfDNA Testing Market Size by Application (2021-2026) & ($ millions)
Table 21. Global cfDNA Testing Market Size Market Share by Application (2021-2026)
Table 22. Global cfDNA Testing Revenue by Player (2021-2026) & ($ millions)
Table 23. Global cfDNA Testing Revenue Market Share by Player (2021-2026)
Table 24. cfDNA Testing Key Players Head office and Products Offered
Table 25. cfDNA Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global cfDNA Testing Market Size by Region (2021-2026) & ($ millions)
Table 29. Global cfDNA Testing Market Size Market Share by Region (2021-2026)
Table 30. Global cfDNA Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 31. Global cfDNA Testing Revenue Market Share by Country/Region (2021-2026)
Table 32. Americas cfDNA Testing Market Size by Country (2021-2026) & ($ millions)
Table 33. Americas cfDNA Testing Market Size Market Share by Country (2021-2026)
Table 34. Americas cfDNA Testing Market Size by Type (2021-2026) & ($ millions)
Table 35. Americas cfDNA Testing Market Size Market Share by Type (2021-2026)
Table 36. Americas cfDNA Testing Market Size by Application (2021-2026) & ($ millions)
Table 37. Americas cfDNA Testing Market Size Market Share by Application (2021-2026)
Table 38. APAC cfDNA Testing Market Size by Region (2021-2026) & ($ millions)
Table 39. APAC cfDNA Testing Market Size Market Share by Region (2021-2026)
Table 40. APAC cfDNA Testing Market Size by Type (2021-2026) & ($ millions)
Table 41. APAC cfDNA Testing Market Size by Application (2021-2026) & ($ millions)
Table 42. Europe cfDNA Testing Market Size by Country (2021-2026) & ($ millions)
Table 43. Europe cfDNA Testing Market Size Market Share by Country (2021-2026)
Table 44. Europe cfDNA Testing Market Size by Type (2021-2026) & ($ millions)
Table 45. Europe cfDNA Testing Market Size by Application (2021-2026) & ($ millions)
Table 46. Middle East & Africa cfDNA Testing Market Size by Region (2021-2026) & ($ millions)
Table 47. Middle East & Africa cfDNA Testing Market Size by Type (2021-2026) & ($ millions)
Table 48. Middle East & Africa cfDNA Testing Market Size by Application (2021-2026) & ($ millions)
Table 49. Key Market Drivers & Growth Opportunities of cfDNA Testing
Table 50. Key Market Challenges & Risks of cfDNA Testing
Table 51. Key Industry Trends of cfDNA Testing
Table 52. Global cfDNA Testing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 53. Global cfDNA Testing Market Size Market Share Forecast by Region (2027-2032)
Table 54. Global cfDNA Testing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 55. Global cfDNA Testing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 56. NIPT by LifeCodexx Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 57. NIPT by LifeCodexx cfDNA Testing Product Offered
Table 58. NIPT by LifeCodexx cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. NIPT by LifeCodexx Main Business
Table 60. NIPT by LifeCodexx Latest Developments
Table 61. Genodive Pharma Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 62. Genodive Pharma cfDNA Testing Product Offered
Table 63. Genodive Pharma cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Genodive Pharma Main Business
Table 65. Genodive Pharma Latest Developments
Table 66. Riken Genesis Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 67. Riken Genesis cfDNA Testing Product Offered
Table 68. Riken Genesis cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Riken Genesis Main Business
Table 70. Riken Genesis Latest Developments
Table 71. GC Genome Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 72. GC Genome cfDNA Testing Product Offered
Table 73. GC Genome cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. GC Genome Main Business
Table 75. GC Genome Latest Developments
Table 76. EDGC Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 77. EDGC cfDNA Testing Product Offered
Table 78. EDGC cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. EDGC Main Business
Table 80. EDGC Latest Developments
Table 81. Natera Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 82. Natera cfDNA Testing Product Offered
Table 83. Natera cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Natera Main Business
Table 85. Natera Latest Developments
Table 86. CareDx Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 87. CareDx cfDNA Testing Product Offered
Table 88. CareDx cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. CareDx Main Business
Table 90. CareDx Latest Developments
Table 91. BillionToOne, Inc. Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 92. BillionToOne, Inc. cfDNA Testing Product Offered
Table 93. BillionToOne, Inc. cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. BillionToOne, Inc. Main Business
Table 95. BillionToOne, Inc. Latest Developments
Table 96. ARUP Laboratories Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 97. ARUP Laboratories cfDNA Testing Product Offered
Table 98. ARUP Laboratories cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. ARUP Laboratories Main Business
Table 100. ARUP Laboratories Latest Developments
Table 101. Guardant Health Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 102. Guardant Health cfDNA Testing Product Offered
Table 103. Guardant Health cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Guardant Health Main Business
Table 105. Guardant Health Latest Developments
Table 106. GRAIL Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 107. GRAIL cfDNA Testing Product Offered
Table 108. GRAIL cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. GRAIL Main Business
Table 110. GRAIL Latest Developments
Table 111. Foundation Medicine Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 112. Foundation Medicine cfDNA Testing Product Offered
Table 113. Foundation Medicine cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Foundation Medicine Main Business
Table 115. Foundation Medicine Latest Developments
Table 116. MedGenome Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 117. MedGenome cfDNA Testing Product Offered
Table 118. MedGenome cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. MedGenome Main Business
Table 120. MedGenome Latest Developments
Table 121. Lucence Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 122. Lucence cfDNA Testing Product Offered
Table 123. Lucence cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Lucence Main Business
Table 125. Lucence Latest Developments
Table 126. BGI Genomics Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 127. BGI Genomics cfDNA Testing Product Offered
Table 128. BGI Genomics cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. BGI Genomics Main Business
Table 130. BGI Genomics Latest Developments
Table 131. Berry Genomics Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 132. Berry Genomics cfDNA Testing Product Offered
Table 133. Berry Genomics cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Berry Genomics Main Business
Table 135. Berry Genomics Latest Developments
Table 136. Burning Rock Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 137. Burning Rock cfDNA Testing Product Offered
Table 138. Burning Rock cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Burning Rock Main Business
Table 140. Burning Rock Latest Developments
Table 141. ACT Genomics Details, Company Type, cfDNA Testing Area Served and Its Competitors
Table 142. ACT Genomics cfDNA Testing Product Offered
Table 143. ACT Genomics cfDNA Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. ACT Genomics Main Business
Table 145. ACT Genomics Latest Developments
LIST OF FIGURES
Figure 1. cfDNA Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global cfDNA Testing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. cfDNA Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. cfDNA Testing Sales Market Share by Country/Region (2025)
Figure 8. cfDNA Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global cfDNA Testing Market Size Market Share by Type in 2025
Figure 10. Global cfDNA Testing Market Size Market Share by Test Type in 2025
Figure 11. Global cfDNA Testing Market Size Market Share Target Audiences in 2025
Figure 12. cfDNA Testing in Prenatal Testing
Figure 13. Global cfDNA Testing Market: Prenatal Testing (2021-2026) & ($ millions)
Figure 14. cfDNA Testing in Oncology
Figure 15. Global cfDNA Testing Market: Oncology (2021-2026) & ($ millions)
Figure 16. cfDNA Testing in Organ Transplant Monitoring
Figure 17. Global cfDNA Testing Market: Organ Transplant Monitoring (2021-2026) & ($ millions)
Figure 18. cfDNA Testing in Others
Figure 19. Global cfDNA Testing Market: Others (2021-2026) & ($ millions)
Figure 20. Global cfDNA Testing Market Size Market Share by Application in 2025
Figure 21. Global cfDNA Testing Revenue Market Share by Player in 2025
Figure 22. Global cfDNA Testing Market Size Market Share by Region (2021-2026)
Figure 23. Americas cfDNA Testing Market Size 2021-2026 ($ millions)
Figure 24. APAC cfDNA Testing Market Size 2021-2026 ($ millions)
Figure 25. Europe cfDNA Testing Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa cfDNA Testing Market Size 2021-2026 ($ millions)
Figure 27. Americas cfDNA Testing Value Market Share by Country in 2025
Figure 28. United States cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC cfDNA Testing Market Size Market Share by Region in 2025
Figure 33. APAC cfDNA Testing Market Size Market Share by Type (2021-2026)
Figure 34. APAC cfDNA Testing Market Size Market Share by Application (2021-2026)
Figure 35. China cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 39. India cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe cfDNA Testing Market Size Market Share by Country in 2025
Figure 42. Europe cfDNA Testing Market Size Market Share by Type (2021-2026)
Figure 43. Europe cfDNA Testing Market Size Market Share by Application (2021-2026)
Figure 44. Germany cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 45. France cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 46. UK cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa cfDNA Testing Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa cfDNA Testing Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa cfDNA Testing Market Size Market Share by Application (2021-2026)
Figure 52. Egypt cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 58. APAC cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 59. Europe cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 61. United States cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 62. Canada cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 63. Mexico cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 64. Brazil cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 65. China cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 66. Japan cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 67. Korea cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 69. India cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 70. Australia cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 71. Germany cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 72. France cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 73. UK cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 74. Italy cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 75. Russia cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 76. Egypt cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 77. South Africa cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 78. Israel cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 79. Turkey cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 80. Global cfDNA Testing Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global cfDNA Testing Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 1. cfDNA Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global cfDNA Testing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. cfDNA Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. cfDNA Testing Sales Market Share by Country/Region (2025)
Figure 8. cfDNA Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global cfDNA Testing Market Size Market Share by Type in 2025
Figure 10. Global cfDNA Testing Market Size Market Share by Test Type in 2025
Figure 11. Global cfDNA Testing Market Size Market Share Target Audiences in 2025
Figure 12. cfDNA Testing in Prenatal Testing
Figure 13. Global cfDNA Testing Market: Prenatal Testing (2021-2026) & ($ millions)
Figure 14. cfDNA Testing in Oncology
Figure 15. Global cfDNA Testing Market: Oncology (2021-2026) & ($ millions)
Figure 16. cfDNA Testing in Organ Transplant Monitoring
Figure 17. Global cfDNA Testing Market: Organ Transplant Monitoring (2021-2026) & ($ millions)
Figure 18. cfDNA Testing in Others
Figure 19. Global cfDNA Testing Market: Others (2021-2026) & ($ millions)
Figure 20. Global cfDNA Testing Market Size Market Share by Application in 2025
Figure 21. Global cfDNA Testing Revenue Market Share by Player in 2025
Figure 22. Global cfDNA Testing Market Size Market Share by Region (2021-2026)
Figure 23. Americas cfDNA Testing Market Size 2021-2026 ($ millions)
Figure 24. APAC cfDNA Testing Market Size 2021-2026 ($ millions)
Figure 25. Europe cfDNA Testing Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa cfDNA Testing Market Size 2021-2026 ($ millions)
Figure 27. Americas cfDNA Testing Value Market Share by Country in 2025
Figure 28. United States cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC cfDNA Testing Market Size Market Share by Region in 2025
Figure 33. APAC cfDNA Testing Market Size Market Share by Type (2021-2026)
Figure 34. APAC cfDNA Testing Market Size Market Share by Application (2021-2026)
Figure 35. China cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 39. India cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe cfDNA Testing Market Size Market Share by Country in 2025
Figure 42. Europe cfDNA Testing Market Size Market Share by Type (2021-2026)
Figure 43. Europe cfDNA Testing Market Size Market Share by Application (2021-2026)
Figure 44. Germany cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 45. France cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 46. UK cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa cfDNA Testing Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa cfDNA Testing Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa cfDNA Testing Market Size Market Share by Application (2021-2026)
Figure 52. Egypt cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries cfDNA Testing Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 58. APAC cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 59. Europe cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 61. United States cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 62. Canada cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 63. Mexico cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 64. Brazil cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 65. China cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 66. Japan cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 67. Korea cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 69. India cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 70. Australia cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 71. Germany cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 72. France cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 73. UK cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 74. Italy cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 75. Russia cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 76. Egypt cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 77. South Africa cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 78. Israel cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 79. Turkey cfDNA Testing Market Size 2027-2032 ($ millions)
Figure 80. Global cfDNA Testing Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global cfDNA Testing Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries cfDNA Testing Market Size 2027-2032 ($ millions)
